Senate Draft Bill Compromises On Profit Incentive For Humanitarian Devices
This article was originally published in The Gray Sheet
Executive Summary
More devices approved under a humanitarian device exemption could be priced for profit if draft Senate language is enacted, but restrictions are included to ensure that current pediatric incentives are not gutted.
You may also be interested in...
Medtech-Supporter Sen. Al Franken To Resign, After Harassment Charges
Sen. Al Franken, D-Minn., who has championed key device regulatory reform changes favoring the medtech industry that are now law, will step down from his post, following newly revealed charges of sexual harassment by a former congressional staffer in 2006.
Fireworks Kept At Bay As Congress Pushes To Enact FDA Reforms By July 4
Bipartisan FDA user fee reauthorization and reform legislation sailed unanimously through the House Energy and Commerce Committee May 10, with many similarities to a Senate version that has also passed out of committee.
Negotiations Continue On Pediatric Device Reauthorization Provisions
Lawmakers in the House and Senate are still hammering out language to allow companies to continue to profit on humanitarian device exemptions with pediatric indications, and to reauthorize a grant program for non-profit pediatric device consortia.